King's College London

Research portal

Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia

Research output: Contribution to journalArticle

Standard

Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia. / Birdir, Cahit ; Fryze, Janina ; Vasiliadis, Haralambos ; Nicolaides, Kypros; Poon, Leona.

In: JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE, 2014.

Research output: Contribution to journalArticle

Harvard

Birdir, C, Fryze, J, Vasiliadis, H, Nicolaides, K & Poon, L 2014, 'Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia', JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE. https://doi.org/10.3109/14767058.2014.937418

APA

Birdir, C., Fryze, J., Vasiliadis, H., Nicolaides, K., & Poon, L. (2014). Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia. JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE. https://doi.org/10.3109/14767058.2014.937418

Vancouver

Birdir C, Fryze J, Vasiliadis H, Nicolaides K, Poon L. Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia. JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE. 2014. https://doi.org/10.3109/14767058.2014.937418

Author

Birdir, Cahit ; Fryze, Janina ; Vasiliadis, Haralambos ; Nicolaides, Kypros ; Poon, Leona. / Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia. In: JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE. 2014.

Bibtex Download

@article{d4b5349740b74be78342c62c4f53ee9e,
title = "Maternal serum anti-M{\"u}llerian hormone at 11-13 weeks{\textquoteright} gestation in the prediction of preeclampsia",
abstract = "Objective: To investigate the potential value of maternal serum anti-M{\"u}llerian hormone (AMH) at 11-13 weeks{\textquoteright} gestation in the prediction of preeclampsia (PE).Methods: The serum concentration of AMH was measured at 11-13 weeks{\textquoteright} gestation in cases of PE (n=50) and normotensive controls (n=150). Backward stepwise multiple regression analysis was used to determine which of the factors amongst the maternal characteristics and gestation were significant predictors of the serum AMH in the control group and from the regression model the value in each case and control was expressed as a multiple of the expected median (MoM). Results: In normotensive pregnancies, the maternal serum concentration of AMH is higher in Afro-Caribbean than in Caucasian women and in smokers than in non-smokers. In the PE group the median serum concentration of AMH was significantly higher than in the controls (2.140 ng/L, IQR 1.968-2.273, vs. 2.062 ng/L, IQR 1.938-2.181, P=0.025), but the median MoM value of AMH was not significantly different between the PE group and the controls (1.040, IQR 0.941-1.081, vs. 0.995, IQR 0.939-1.065, P=0.147).Conclusions: Maternal serum AMH is not an effective early predictor for PE.",
author = "Cahit Birdir and Janina Fryze and Haralambos Vasiliadis and Kypros Nicolaides and Leona Poon",
year = "2014",
doi = "10.3109/14767058.2014.937418",
language = "English",
journal = "JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE",
issn = "1476-7058",
publisher = "Taylor & Francis",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia

AU - Birdir, Cahit

AU - Fryze, Janina

AU - Vasiliadis, Haralambos

AU - Nicolaides, Kypros

AU - Poon, Leona

PY - 2014

Y1 - 2014

N2 - Objective: To investigate the potential value of maternal serum anti-Müllerian hormone (AMH) at 11-13 weeks’ gestation in the prediction of preeclampsia (PE).Methods: The serum concentration of AMH was measured at 11-13 weeks’ gestation in cases of PE (n=50) and normotensive controls (n=150). Backward stepwise multiple regression analysis was used to determine which of the factors amongst the maternal characteristics and gestation were significant predictors of the serum AMH in the control group and from the regression model the value in each case and control was expressed as a multiple of the expected median (MoM). Results: In normotensive pregnancies, the maternal serum concentration of AMH is higher in Afro-Caribbean than in Caucasian women and in smokers than in non-smokers. In the PE group the median serum concentration of AMH was significantly higher than in the controls (2.140 ng/L, IQR 1.968-2.273, vs. 2.062 ng/L, IQR 1.938-2.181, P=0.025), but the median MoM value of AMH was not significantly different between the PE group and the controls (1.040, IQR 0.941-1.081, vs. 0.995, IQR 0.939-1.065, P=0.147).Conclusions: Maternal serum AMH is not an effective early predictor for PE.

AB - Objective: To investigate the potential value of maternal serum anti-Müllerian hormone (AMH) at 11-13 weeks’ gestation in the prediction of preeclampsia (PE).Methods: The serum concentration of AMH was measured at 11-13 weeks’ gestation in cases of PE (n=50) and normotensive controls (n=150). Backward stepwise multiple regression analysis was used to determine which of the factors amongst the maternal characteristics and gestation were significant predictors of the serum AMH in the control group and from the regression model the value in each case and control was expressed as a multiple of the expected median (MoM). Results: In normotensive pregnancies, the maternal serum concentration of AMH is higher in Afro-Caribbean than in Caucasian women and in smokers than in non-smokers. In the PE group the median serum concentration of AMH was significantly higher than in the controls (2.140 ng/L, IQR 1.968-2.273, vs. 2.062 ng/L, IQR 1.938-2.181, P=0.025), but the median MoM value of AMH was not significantly different between the PE group and the controls (1.040, IQR 0.941-1.081, vs. 0.995, IQR 0.939-1.065, P=0.147).Conclusions: Maternal serum AMH is not an effective early predictor for PE.

U2 - 10.3109/14767058.2014.937418

DO - 10.3109/14767058.2014.937418

M3 - Article

JO - JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE

JF - JOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE

SN - 1476-7058

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454